InMode - Envision

The human eye is one of the most important sensory organs, extracting and processing more than 10 million pieces of information per second and blinking 15-20 times per minute on average. For many, eyes can be the source of chronic and constant discomfort. Meibomian Gland Dysfunction (MGD) is a major cause of ocular discomfort. In Australia, 77% have experienced dry eye symptoms, yet many do not have a clear understanding of the signs, symptoms or causes, according to a study by eyecare company Alcon.

Dry eye is a chronic condition affecting about one-third of Australian adults and half of those aged over 50.1 Females are at greater risk of developing the condition. Envision is the new in-office standard revolutionising ocular care procedures for the treatment of meibomian gland dysfunction and the symptoms of dry eyes.

This comprehensive, non-surgical ophthalmic device, deploys multiple programmable modalities which work synergistically to deliver precision ocular treatments:

• Forma-I: bipolar radiofrequency (RF)

• Lumecca-I: intense pulse light (IPL)

• Morpheus8: fractional radiofrequency (RF) micro needling technology

Envision’s small-size applicators and precise depth control allow for safe and highly efficacious procedures in the small, more delicate subdermal layers of the periorbital region. With Envision, practitioners deliver non-drug therapies to improve patient vision and quality of life.

View More Here.

Download Brochure